October 27, 2025

CA Immo Signed Lease Extension for AstraZeneca in Warsaw

On October 21, 2021, CA Immo announced that it had signed a lease extension agreement in the Warsaw office building Postepu 14 with AstraZeneca Pharma Poland for another five years, also leasing an additional 3,000 square meters of workspace.

The seat of AstraZeneca Pharma Poland in Warsaw will amount to approximately 21,000 square meters, which represents more than 60% of the building’s entire area. AstraZeneca has been present in Poland for 30 years and employs nearly 2,300 people locally. The Warsaw branch of the company, which has been operating in the 14 Postepu building since 2016, is expanding again.

“This agreement was concluded less than a year after we purchased the building in 2020, which confirms our investment decision,” stated CA Immo Poland Managing Director Andrzej Mikolajczyk. “The Postepu 14 office building is a great asset in terms of quality and location, meeting the expectations of well-known, international companies. I would like to thank the Management Team of AstraZeneca for their trust and we look forward to furthering [the] fruitful cooperation.”

 

 

Get the memo – every week

Essential real estate market updates, straight to your inbox.

GTC Boasts First LEED Gold v5 Building in CEE

According to the developer, this is only the fourth existing building in Europe to achieve this recognition, following projects in Italy, Spain, and Sweden.

Renters Acquires Irundo–Short Term Rentals

Irundo–Short Term Rentals is a Croatian short-term rentals company. The company was founded 15 years ago and manages over 300 apartments across top tourist destinations.

Kemberton Issues PLN 120 Million Bonds

Proceeds from the new bond issue were used to redeem part of the PLN 170 million of Ghelamco Invest bonds held by retail and institutional investors, which matured on September 29, 2025.